2021
DOI: 10.1016/j.envres.2020.110361
|View full text |Cite
|
Sign up to set email alerts
|

Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
40
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(44 citation statements)
references
References 38 publications
4
40
0
Order By: Relevance
“…In this prior work, the relationship between PFNA and CRH was stronger among women who experienced stress, indicating a joint effect of chemical and non-chemical stressors on CRH ( Eick et al, 2022 ). Other pathways may be through inflammation, as studies have linked depression to elevated maternal biomarkers of inflammation and recent work suggests that PFAS are also associated with chronic inflammation ( Omoike et al, 2021 ; Lahti-Pulkkinen et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…In this prior work, the relationship between PFNA and CRH was stronger among women who experienced stress, indicating a joint effect of chemical and non-chemical stressors on CRH ( Eick et al, 2022 ). Other pathways may be through inflammation, as studies have linked depression to elevated maternal biomarkers of inflammation and recent work suggests that PFAS are also associated with chronic inflammation ( Omoike et al, 2021 ; Lahti-Pulkkinen et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“… 15 , 16 In addition, FAS exposure is associated with increased inflammatory markers and oxidative stress. 14 , 36 Given the systemic effects which can be induced by both oxidative stress and PPARα dysregulation, the combination of these two molecular actors may in part explain the broad health effects observed in association with PFAS exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Overall, MetS is a cluster of interrelated risk factors (obesity, insulin resistance, dyslipidemia, and hypertension) all known as risk factors of cardiovascular diseases (CVD), therefore different mode of action/adverse outcome pathways (AOPs) of PFAS could influence the final results [14,43]. For instance, the PFAS-to-lipid associations are explained in animal studies by transactivation of peroxisome proliferator-activated receptor α (PPARα) contributing to a liver metabolic pathway which plays an important role in the regulation of cholesterol and triglyceride levels; or oxidative stress has been proposed to be a key player in the pathogenesis of hypertension [44][45][46][47]. Other putative molecular initiating/key events for PFAS might be explained by mitochondrial dysfunction, interference of protein binding, partitioning into lipid bilayers (enterohepatic cycling of both bile acids and PFAS), altered calcium homeostasis, and inappropriate activation of molecular signals controlling cell functions [14,48].…”
Section: Discussionmentioning
confidence: 99%